Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin Digital Health, American College of Cardiology introduce Digital Therapeutics Certificate for Cardiologists in India

Written By Ruchika Sharma31 Jan 2024 2:30 PM IST

Mumbai: Lupin Digital Health, an evidence-based cardiology Digital Therapeutics (DTx) platform and the American College of Cardiology (ACC) have...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca Enhertu granted priority review in US for metastatic HER2-positive solid tumours

Written By Ruchika Sharma31 Jan 2024 12:45 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been...

GSK Omjjara gets European Commission marketing authorisation

Written By Ruchika Sharma29 Jan 2024 4:45 PM IST

London: GSK plc has announced the European Commission has granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare gets 2 observations from AGES, Austria for Unit 4 of Jadcherla facility

Written By Ruchika Sharma29 Jan 2024 3:30 PM IST

Karnataka: Shilpa Medicare has received two minor observations from AGES, Austria at the conclusion of a Europe GMP inspection at the...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer ordered to pay USD 2.25 billion in latest Roundup trial

Written By Ruchika Sharma29 Jan 2024 12:30 PM IST

Bayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller,...

Haleon recalls some lots of adult cough syrup Robitussin over microbial contamination

Written By Ruchika Sharma29 Jan 2024 10:00 AM IST

Haleon is recalling some lots of its adult cough syrup Robitussin because of microbial contamination, the U.S. Food and Drug Administration (FDA) has...

Maharashtra Boosts Support for Leprosy Hospitals Amid Rising Cases

Centre to introduce three drug treatment regime to stop leprosy transmission by 2027

Written By Ruchika Sharma28 Jan 2024 5:00 PM IST

New Delhi: The Union Health Ministry has decided to implement a new treatment regimen for leprosy aimed at stopping its transmission at the...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi Dupixent approved by USFDA for pediatric patients aged 1 to 11 years with eosinophilic esophagitis

Written By Ruchika Sharma28 Jan 2024 2:30 PM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of...

Pfizer Secures Vyndamax Patent Till 2031

EMA validates Type II variation application for Padcev with Keytruda for first line treatment of advanced Bladder Cancer: Pfizer

Written By Ruchika Sharma28 Jan 2024 10:00 AM IST

Tokyo: Astellas Pharma Inc. and Pfizer Inc. have announced that the European Medicines Agency (EMA) has validated for review a Type II...

Illegal Clinic Allegations Trigger Health Department Raid in Odisha

Raid at illegal medical shop, medicines worth Rs 3.20 lakh seized

Written By Ruchika Sharma27 Jan 2024 1:30 PM IST

111 varieties of medicines, including habit-forming drugs, antibiotics, insulin injections, anti-viral drugs, anti-hypertensive drugs, painkillers,...

Strides Pharma Science arm voluntarily dissolves

Strides Pharma Science Singapore arm gets USFDA okay for fibromyalgia drug Pregabalin

Written By Ruchika Sharma27 Jan 2024 12:30 PM IST

Bangalore: Strides Pharma Science Limited has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has...

Marksans Pharma UK arm Relonchem gets marketing nod for high BP drug

Zydus Lifesciences bags USFDA nod for Gabapentin Tablets (Once-Daily) for Postherpetic Neuraligia management

Written By Ruchika Sharma27 Jan 2024 11:44 AM IST

Following approval, the product will be launched immediately in the US.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok